🇺🇸 FDA
Patent

US 8575185

Compositions, synthesis, and methods of utilizing quinazolinedione derivatives

granted A61KA61K31/538A61P

Quick answer

US patent 8575185 (Compositions, synthesis, and methods of utilizing quinazolinedione derivatives) held by REVIVA PHARMACEUTICALS, INC. expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REVIVA PHARMACEUTICALS, INC.
Grant date
Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/538, A61P, A61P25/00, A61P25/18